These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23537420)

  • 1. Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemia.
    Bay C; Kristensen PL; Pedersen-Bjergaard U; Tarnow L; Thorsteinsson B
    Diabetes Technol Ther; 2013 May; 15(5):371-7. PubMed ID: 23537420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes.
    Calhoun P; Lum J; Beck RW; Kollman C
    Diabetes Technol Ther; 2013 Sep; 15(9):758-61. PubMed ID: 23725474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia.
    Mahmoudi Z; Jensen MH; Dencker Johansen M; Christensen TF; Tarnow L; Christiansen JS; Hejlesen O
    Diabetes Technol Ther; 2014 Oct; 16(10):667-78. PubMed ID: 24918271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
    Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
    Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of retrospective calibration algorithms on hypoglycemia detection in newborn infants using continuous glucose monitoring.
    Signal M; Le Compte A; Harris DL; Weston PJ; Harding JE; Chase JG;
    Diabetes Technol Ther; 2012 Oct; 14(10):883-90. PubMed ID: 22856622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
    Zueger T; Diem P; Mougiakakou S; Stettler C
    Diabetes Technol Ther; 2012 Jul; 14(7):583-8. PubMed ID: 22512266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
    Brøsen JMB; Agesen RM; Alibegovic AC; Ullits Andersen H; Beck-Nielsen H; Gustenhoff P; Krarup Hansen T; Hedetoft CGR; Jensen TJ; Stolberg CR; Bogh Juhl C; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2022 Sep; 24(9):643-654. PubMed ID: 35467938
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of continuous glucose monitoring as an outcome measure in clinical trials.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2012 Oct; 14(10):877-82. PubMed ID: 23013201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
    Thabit H; Leelarathna L; Wilinska ME; Elleri D; Allen JM; Lubina-Solomon A; Walkinshaw E; Stadler M; Choudhary P; Mader JK; Dellweg S; Benesch C; Pieber TR; Arnolds S; Heller SR; Amiel SA; Dunger D; Evans ML; Hovorka R
    Diabetes Technol Ther; 2015 Nov; 17(11):801-7. PubMed ID: 26241693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Relationships Between Measures of Glycemic Control and Hypoglycemia in Continuous Glucose Monitoring Data Sets.
    Gimenez M; Tannen AJ; Reddy M; Moscardo V; Conget I; Oliver N
    Diabetes Care; 2018 Feb; 41(2):326-332. PubMed ID: 29191845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
    Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
    Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
    Stewart ZA; Thomson L; Murphy HR; Beardsall K
    Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
    De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
    Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.